BBHC
SNY icon

Brown Brothers Harriman & Co’s Sanofi SNY Stock Holding History

Brown Brothers Harriman & Co’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$56.8K Sell
1,178
-826
-41% -$38.5K ﹤0.01% 1026
2025
Q4 		$97.1K Sell
2,004
-267
-12% -$13.2K ﹤0.01% 909
2025
Q3 		$107K Buy
2,271
+1,955
+619% +$94.4K ﹤0.01% 850
2025
Q2 		$15.3K Buy
+316
New +$16.1K ﹤0.01% 1133
2025
Q1 		– Sell
-500
Closed -$24.1K – 1473
2024
Q4 		$24.1K Hold
500
– – ﹤0.01% 992
2024
Q3 		$28.8K Sell
500
-4,148
-89% -$224K ﹤0.01% 884
2024
Q2 		$226K Sell
4,648
-1,925
-29% -$92.9K ﹤0.01% 525
2024
Q1 		$319K Buy
6,573
+479
+8% +$23.4K ﹤0.01% 445
2023
Q4 		$303K Sell
6,094
-966
-14% -$47.2K ﹤0.01% 429
2023
Q3 		$379K Buy
7,060
+982
+16% +$52.4K ﹤0.01% 380
2023
Q2 		$328K Sell
6,078
-614
-9% -$33K ﹤0.01% 388
2023
Q1 		$364K Buy
6,692
+614
+10% +$29.9K ﹤0.01% 386
2022
Q4 		$294K Sell
6,078
-1,020
-14% -$44.8K ﹤0.01% 392
2022
Q3 		$270K Buy
7,098
+582
+9% +$25.9K ﹤0.01% 398
2022
Q2 		$326K Buy
6,516
+368
+6% +$19.5K ﹤0.01% 379
2022
Q1 		$316K Buy
6,148
+5,517
+874% +$285K ﹤0.01% 416
2021
Q4 		$32 Buy
631
+131
+26% +$6.48K ﹤0.01% 774
2021
Q3 		$24 Hold
500
– – ﹤0.01% 794
2021
Q2 		$26 Hold
500
– – ﹤0.01% 771
2021
Q1 		$25 Sell
500
-1,293
-72% -$62.1K ﹤0.01% 751
2020
Q4 		$87K Buy
1,793
+196
+12% +$9.67K ﹤0.01% 582
2020
Q3 		$80K Sell
1,597
-205
-11% -$10.6K ﹤0.01% 516
2020
Q2 		$92K Buy
1,802
+1,161
+181% +$56.4K ﹤0.01% 497
2020
Q1 		$28K Sell
641
-1,222
-66% -$58.5K ﹤0.01% 589
2019
Q4 		$94K Buy
1,863
+1,028
+123% +$48.2K ﹤0.01% 575
2019
Q3 		$39K Sell
835
-7,695
-90% -$332K ﹤0.01% 689
2019
Q2 		$369K Sell
8,530
-706
-8% -$30K ﹤0.01% 306
2019
Q1 		$409K Buy
9,236
+8,736
+1,747% +$374K ﹤0.01% 285
2018
Q4 		$22K Hold
500
– – ﹤0.01% 618
2018
Q3 		$22K Sell
500
-4,199
-89% -$179K ﹤0.01% 609
2018
Q2 		$188K Hold
4,699
– – ﹤0.01% 345
2018
Q1 		$188K Buy
4,699
+4,199
+840% +$175K ﹤0.01% 336
2017
Q4 		$22K Hold
500
– – ﹤0.01% 636
2017
Q3 		$25K Hold
500
– – ﹤0.01% 569
2017
Q2 		$24K Hold
500
– – ﹤0.01% 573
2017
Q1 		$23K Hold
500
– – ﹤0.01% 578
2016
Q4 		$20K Hold
500
– – ﹤0.01% 626
2016
Q3 		$19K Hold
500
– – ﹤0.01% 558
2016
Q2 		$21K Sell
500
-400
-44% -$16.4K ﹤0.01% 552
2016
Q1 		$36K Buy
900
+400
+80% +$16.1K ﹤0.01% 472
2015
Q4 		$21K Sell
500
-1,766
-78% -$81.2K ﹤0.01% 561
2015
Q3 		$108K Sell
2,266
-573
-20% -$29.2K ﹤0.01% 395
2015
Q2 		$141K Sell
2,839
-3,096
-52% -$157K ﹤0.01% 374
2015
Q1 		$293K Sell
5,935
-709
-11% -$33.9K ﹤0.01% 306
2014
Q4 		$303K Sell
6,644
-2,311
-26% -$112K ﹤0.01% 308
2014
Q3 		$505K Buy
8,955
+579
+7% +$31.1K ﹤0.01% 263
2014
Q2 		$445K Sell
8,376
-3,850
-31% -$204K ﹤0.01% 273
2014
Q1 		$639K Sell
12,226
-444
-4% -$22.5K ﹤0.01% 223
2013
Q4 		$679K Buy
12,670
+1,323
+12% +$68.3K ﹤0.01% 213
2013
Q3 		$574K Buy
11,347
+112
+1% +$5.7K ﹤0.01% 220
2013
Q2 		$579K Buy
+11,235
New +$599K ﹤0.01% 267

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Brown Brothers Harriman & Co's SNY Position: Q1 2026 in Review

Brown Brothers Harriman & Co reduced its Sanofi (SNY) stake by 41% in Q1 2026, selling an estimated $38.5K and leaving 1,178 shares worth $56.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1026.

Brown Brothers Harriman & Co first reported a position in SNY in Q2 2013 and has held it in 51 quarters since. The position peaked at $679K in Q4 2013. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Brown Brothers Harriman & Co held 1,178 shares of Sanofi worth $56.8K as of Q1 2026.
  • Brown Brothers Harriman & Co sold 826 Sanofi shares in Q1 2026, an estimated $38.5K.
  • Sanofi made up ﹤0.01% of Brown Brothers Harriman & Co's portfolio in Q1 2026, its #1026 holding.
  • Brown Brothers Harriman & Co first reported a position in Sanofi in Q2 2013 and has held it in 51 quarters since.
  • Brown Brothers Harriman & Co's Sanofi position peaked at $679K in Q4 2013.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q1 2026, filed 14 May 2026.